Literature DB >> 12153620

Liver fluke-associated cholangiocarcinoma.

P Watanapa1, W B Watanapa.   

Abstract

BACKGROUND: Infection with liver flukes has been reported to be associated with bile duct malignancy.
METHODS: The review is based on a literature search (Medline) and, in some cases, direct contact with authors or principal investigators.
RESULTS: A large body of evidence indicates that Opisthorchis viverrini is a definite cause of human cholangiocarcinoma, whereas Clonorchis sinensis is a probable cause. The evidence regarding Opisthorchis felineus is insufficient to assess its role in carcinogenesis. Possible mechanisms of carcinogenesis include chronic irritation, nitric oxide formation, intrinsic nitrosation and activation of drug-metabolizing enzymes. Early detection of bile duct malignancy is difficult and not clinically available at present, although cholangiocarcinoma-associated soluble antigen has been reported in an experimental study to be a useful early marker of cancer development. Long-term survival after surgical treatment of liver fluke-associated cancer is similar to that reported in patients without liver fluke infestation.
CONCLUSION: Liver fluke-associated cholangiocarcinoma is still a health problem in developing countries. Mechanisms of carcinogenesis should be explored further in order to reduce the impact of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153620     DOI: 10.1046/j.1365-2168.2002.02143.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  80 in total

Review 1.  Clonorchis sinensis-associated cholangiocarcinoma: a case report and review of the literature.

Authors:  Georgios I Papachristou; Karen E Schoedel; Ramesh Ramanathan; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

2.  Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.

Authors:  Upama Liengswangwong; Anant Karalak; Yukio Morishita; Masayuki Noguchi; Thiravud Khuhaprema; Petcharin Srivatanakul; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Biliary parasites: diagnostic and therapeutic strategies.

Authors:  Niraj Khandelwal; Joanna Shaw; Mamta K Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2008-04

Review 4.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

5.  Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.

Authors:  Mirna H Farhat; Ali I Shamseddine; Ayman N Tawil; Ghina Berjawi; Charif Sidani; Wael Shamseddeen; Kassem A Barada
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

Review 6.  Cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  Ghulam Abbas; Keith D Lindor
Journal:  J Gastrointest Cancer       Date:  2009-08-25

7.  Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.

Authors:  Nimzing G Ladep; Shahid A Khan; Mary Me Crossey; Andrew V Thillainayagam; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

8.  Intrahepatic cholangiocarcinoma with old infestation of Schistosoma japonicum: report of a case.

Authors:  Tomotaka Akatsu; Motohide Shimazu; Masahiro Shinoda; Shigeyuki Kawachi; Minoru Tanabe; Koichi Aiura; Masakazu Ueda; Kaori Kameyama; Michiie Sakamoto; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

9.  Chronic schistosomiasis japonica is an independent adverse prognostic factor for survival in hepatocellular carcinoma patients who have undergone hepatic resection: clinicopathological and prognostic analysis of 198 consecutive patients.

Authors:  Masanori Matsuda; Hideki Fujii
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

Review 10.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.